TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastasesCarey K. Anders, Lisa A. Carey, Vandana G. Abramson et al.|Breast Cancer Research and Treatment|2014Cited by 69